GTS Securities’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-43,400
Closed -$9.58M 1798
2024
Q3
$9.58M Buy
43,400
+8,400
+24% +$1.74M 0.02% 532
2024
Q2
$6.88M Buy
35,000
+3,400
+11% +$702K 0.01% 673
2024
Q1
$6.8M Sell
31,600
-9,900
-24% -$2.08M 0.01% 681
2023
Q4
$8.74M Buy
41,500
+5,300
+15% +$1.13M 0.01% 676
2023
Q3
$7.25M Buy
+36,200
New +$7.2M 0.01% 742

Other funds holding CME

GTS Securities's CME Position: Q1 2026 in Review

GTS Securities reduced its CME Group (CME) stake by 49% in Q1 2026, selling an estimated $784K and leaving 2,754 shares worth $813K. The position accounts for 0.03% of the portfolio, ranked #481.

GTS Securities first reported a position in CME in Q2 2023 and has held it in 12 quarters since. The position peaked at $2.92M in Q4 2023. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • GTS Securities held 2,754 shares of CME Group worth $813K as of Q1 2026.
  • GTS Securities sold 2,640 CME Group shares in Q1 2026, an estimated $784K.
  • CME Group made up 0.03% of GTS Securities's portfolio in Q1 2026, its #481 holding.
  • GTS Securities first reported a position in CME Group in Q2 2023 and has held it in 12 quarters since.
  • GTS Securities's CME Group position peaked at $2.92M in Q4 2023.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.